These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24333562)

  • 1. Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes.
    Rodriguez MP; Emond ZM; Wang Z; Martinez J; Jiang Q; Kibbe MR
    Nitric Oxide; 2014 Jan; 36():67-75. PubMed ID: 24333562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide differentially affects ERK and Akt in type 1 and type 2 diabetic rats.
    Rodriguez MP; Emond ZM; Varu VN; Ahanchi SS; Martinez J; Kibbe MR
    J Surg Res; 2013 Aug; 183(2):944-951. PubMed ID: 23608617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes.
    Varu VN; Ahanchi SS; Hogg ME; Bhikhapurwala HA; Chen A; Popowich DA; Vavra AK; Martinez J; Jiang Q; Saavedra JE; Hrabie JA; Keefer LK; Kibbe MR
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H772-9. PubMed ID: 20562340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats.
    Tsihlis ND; Rodriguez MP; Jiang Q; Schwartz A; Flynn ME; Vercammen JM; Kibbe MR
    J Surg Res; 2016 May; 202(2):413-21. PubMed ID: 27229117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats.
    Rodriguez MP; Tsihlis ND; Emond ZM; Wang Z; Varu VN; Jiang Q; Vercammen JM; Kibbe MR
    J Surg Res; 2015 Jun; 196(1):180-9. PubMed ID: 25801975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin enhances neointimal hyperplasia following arterial injury through the PI3K/Akt pathway in type 1 diabetic rats.
    Cai J; Wang H; Sang H; Ye R; Cao Y; Jing M; Liu K; Xie Y; Qiu Z; Guo R; Lv Q; Liu X
    Mol Med Rep; 2020 Dec; 22(6):5472-5478. PubMed ID: 33174004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.
    Ahanchi SS; Varu VN; Tsihlis ND; Martinez J; Pearce CG; Kapadia MR; Jiang Q; Saavedra JE; Keefer LK; Hrabie JA; Kibbe MR
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2388-98. PubMed ID: 18931034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle levels after arterial injury and NO therapy in diabetes.
    Wang Z; Emond ZM; Flynn ME; Swaminathan S; Kibbe MR
    J Surg Res; 2016 Feb; 200(2):722-31. PubMed ID: 26490225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
    Park SH; Marso SP; Zhou Z; Foroudi F; Topol EJ; Lincoff AM
    Circulation; 2001 Aug; 104(7):815-9. PubMed ID: 11502708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats.
    Buglak NE; Jiang W; Bahnson ESM
    Redox Biol; 2018 Oct; 19():166-178. PubMed ID: 30172101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.
    Bahnson ES; Koo N; Cantu-Medellin N; Tsui AY; Havelka GE; Vercammen JM; Jiang Q; Kelley EE; Kibbe MR
    Nitric Oxide; 2015 Jan; 44():8-17. PubMed ID: 25460325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats.
    Desouza CV; Gerety M; Hamel FG
    Atherosclerosis; 2006 Feb; 184(2):283-9. PubMed ID: 15941566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.
    Hogg ME; Varu VN; Vavra AK; Popowich DA; Banerjee MN; Martinez J; Jiang Q; Saavedra JE; Keefer LK; Kibbe MR
    Free Radic Biol Med; 2011 May; 50(9):1065-74. PubMed ID: 21256959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.
    Kapadia MR; Chow LW; Tsihlis ND; Ahanchi SS; Eng JW; Murar J; Martinez J; Popowich DA; Jiang Q; Hrabie JA; Saavedra JE; Keefer LK; Hulvat JF; Stupp SI; Kibbe MR
    J Vasc Surg; 2008 Jan; 47(1):173-82. PubMed ID: 18178471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.
    Tsihlis ND; Vavra AK; Martinez J; Lee VR; Kibbe MR
    Nitric Oxide; 2013 Nov; 35():165-74. PubMed ID: 24149190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG.
    Gong Z; Han Y; Wu L; Xia T; Ren H; Yang D; Gu D; Wang H; Hu C; He D; Zhou L; Zeng C
    Life Sci; 2019 Mar; 221():72-82. PubMed ID: 30738868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome.
    Barbato JE; Zuckerbraun BS; Overhaus M; Raman KG; Tzeng E
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H228-36. PubMed ID: 15734883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.
    Indolfi C; Torella D; Cavuto L; Davalli AM; Coppola C; Esposito G; Carriero MV; Rapacciuolo A; Di Lorenzo E; Stabile E; Perrino C; Chieffo A; Pardo F; Chiariello M
    Circulation; 2001 Jun; 103(24):2980-6. PubMed ID: 11413090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.
    Zhang WX; Tai GJ; Li XX; Xu M
    Free Radic Biol Med; 2019 Nov; 143():153-163. PubMed ID: 31369842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.